The transition from one cell function to another, as well as the transition of one cell type to another seems to be a routine event rather than a rare one. It has been shown that an epithelial mesenchymal transition (EMT) in embryogenesis/morphogenesis acts in a direction opposite to that of a mesenchymal-epithelial transition (MET) [Cell 2009, 139(5):871–890]. Furthermore, EMT can induce non-cancer stem cells to become cancer stem cells [Cell 2008, 133(4):704–715 & PLoS One 2008, 3(8):e2888].
Braun recognized some 60 y ago that a gram negative bacterium Agrobacterium tumefaciens could initiate the in vitro transformation of normal plant cells into tumor cells; he showed that transformation occurs in a short time period, resulting in tumor cells with slower growth and less progression [Am J Biol 1947, 34(4):234–240 & Proc Natl Acad Sci U S A 1958, 44(4):344–349 & Phytopathology 1951, 41:963–966]. Zaenen et al. revealed, and Mary-Ann Chilton’s group subsequently proved, that a small DNA plasmid within A. tumefaciens was responsible for the transformation [J Mol Biol 1974, 86(1):109–127.]: tumor inducing DNA (Ti-DNA), after infection, was integrated into the plant genome in tobacco plants [Cell 1977, 11(2):263–271]. Chilton also showed that Braun’s findings were based on the same principle: although the T-DNA from the A. tumefaciens Ti-plasmids was not at first detected [Proc Natl Acad Sci U S A 1974, 71(9):3672–3676], it was later proven to be in the nuclear DNA fraction of crown-gall tumors [Proc Natl Acad Sci U S A 1980, 77(7):4060–4064]. More evidence comes from research on mesothelial cells. In 1966, Eskeland, based on silver-staining electron microscopy studies, first suggested that injured or destroyed mesothelial cells are replaced in location and function by free-floating “peritoneal macrophages,” which are transformed from their original role to that of mesothelial cells [Acta Pathol Microbiol Scand 1966, 68(3):379–395 & Acta Pathol Microbiol Scand 1966, 68(3):353–378.].
As a consequence of a pathogenic stimulus such as inflammation or wound healing, EMT can change MCs into cells with mesenchymal or epithelial characteristics [Int J Biochem Cell Biol 1997, 29(1):5–17]. Recently it was reported that the transition from one cell function to another, as well as the transition of one cell type to another seems to be a routine event rather than a rare one [BMC Cancer. 2014 May 10;14:331] AND due to the above findings within the human, animal and plant kingdom it was proposed that carcinogenesis occurs by a multistep sequence and that its last step is a transition of a normal cell into a cancer cell.
http://www.biomedcentral.com/content/pdf/1471-2407-14-331.pdf
An actual paper in PLoS ONE 2015 supports the proposal as chronic lung injury results into a transition of a normal cell into a cancer cell.
Kitamura et al.: Chronic Lung Injury by Constitutive Expression of Activation-Induced Cytidine Deaminase Leads to Focal Mucous Cell Metaplasia and Cancer. PLoS One. 2015 Feb 6;10(2):e0117986.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117986
A VERY DIFFICULT QUESTION TO ANSWER BUT IN NORMAL EMBRYOGENESIS AS YOU DISCUSSED THE ROLES OF HOW A PLACENTA NORMALLY INVADES AND ROLES OF VARIOUS ADAM/TACE FUNCTIONS, and roles of various EGF receptors MMPS etc IT IS NORMALLY SEEN THAT EVEN NO GESTATIONAL TROPHOBLASTIC DISEASE DEVELOPS AND PLACENTAL INVASION REMAINS LIMITED WITH THE USE OF PROKINETICINS and limited VEGF whatever is required but sometimes one comes across cases where ou meet gestationalchorio carcinoma and i happened to see a very interesting case of a youngunmarried girl with no history of contact presenting with a solid intrauterine tumour which kept n increasing and reached 26 weeks pregnant uterus size and MRI pictures revealed a highly invasive tumour in myometrium and with an unmarried girl whokept on bleeding profusely with markedly getting deranged immune system and repeated bouts of super infection nodiagnosiswasbeing made and ultimately ahe was kept for aTAH with BSO and although she had a transrectal biosy which showed HCG staining villi no diagnosis was made when i first saw her and decided totry to treat her as a case of nongeatational choriocarcinoma of uterine body and gave her EMA-CO therapy after treating her infections with iv antibiotics and blood transfusions and gradually her tumor shrunk and loss anchor from myometrium and she expelled a huge tumor vagially -although this was totally against conventional norms of a 26wks choriocarc8inoma with a vrty low secreting hcgand sometimes i got a negative uot and beta hcg fluctated around 1200 in contrast to lakhs in a 26 weeks ize choriocarcinoma although i tried to publish in gyneoncology nobody knew what the diagnosis fitted nto although it isa wonder i will send youall her MRIS as well asc photographs but it is a surprise how a transformationoccurs and this penetration beyond myometrium occurs and kkeeps occuring and what would lne put this into as an initiating factorbbecause this tumor was just rapidly increasing in size ad unmarried girl with intact hymen .
Coexistence of cancer and normal cells in a predator pray relationship is the consequence of the disturbed signal transmission, mediated by direct cell contacts and by small molecules similar to quorum sensing. .
yeap, I agree Joseph, as the signaling paths are the ain regulators, lthough we already know, that many variables influence genes alone by themelves but as we increasingly see, it wouldbe myoptic thinking genes are responsible for it, thanks again
There is necessity reminding us and the youth for increasingly learning from the animal AND plant kingdom fr its future understanding of carcinogenesis.
It is something completely different, if an observation was done in advanced cancer tissues or in sequences of carcinogenesis, but it seems, that increasingly correct observations in cancer tissues investigations had been and still are wrongly mislead for being a synonym of prove for carcinogenesis. It is of doubt, that someone would find an apple in a car and would mislead it with the wrong conclusion that apples grow in cars.
The quality of chronic injury , we can call "inflammation" mentioned by Björn seems to be important in the intiation of carcinogenesis,if we take into conideration of the increased lung cancer cases in the last few decades. In case of cancer induction different injuries may have the same response. One of the opportunities genetical changes: for example when we eliminated the Ti plasmid by tricyclic compound from A.tumefaciens, the bacteria lost the tumor inducing property on tobacco plants as a consequence of the elimination of a pice of extrachromosomal DNA. Similar plasmid elimination was observed in case of antibiotic resistance genes or haemolysin transporter or bacteriocin or virulence encoding plasmids. This is only one type of examples of the enviromentally induced phenotypic changes.Possibly other types of environmental effects can be responsible for common changes in the cell population which leads uncontrolled cell growth on the expense of the host.
Cancer and normal tissue relationship starts somewhere, where some normal cells forget to consider the contact inhibition and the direction of growth rate into the minimum entropy production. Some cells invade the surrounding normal tissues grow towards entropy maximum without any sign of cellular and humoral inflammatory reactions. The only perspective remain for cancer to survive as a self-parasite is based on the comparison of the directions of entropy flows between normal and cancer tissues.The irreversible processes communicated via various dissipation mechanisms.
Based on the Second principle there is no opportunity to create entropy barrier.The 2nd law does not exclude the opportunity to reverse some entropy flows by application of external force fields We suppose that the 2nd law allows to change the direction of components of informational entropy from tumor to normal tissues by application of specific external forces if the direction of some cancer specific components of entropy flow can be reversed.
I think You are right. The negative entropy of normal tissue has a possible role in the tumor growth ( Molnar at al, LDDD 2,429-438, 2005.)
I would argue that a pathological biological or chemical stimulus is the entry.
Björn is right in raising up the role of pathological, biological and chemical stimulus for initiation., this can explain the inherited susceptibility to various malignancies. There are patients with frequently reccuring basaliomas and patients with inherited susceptibility of developing lung or colon or other cancers. Endogenous signals and exogenous stimuli may be important at the beginning of tumorigenenesis similarly to various inflamatory processes..
Adaptation interests me. It could also include chronic inflammation. One of the best example is barrett's esophagus I think. I do not know if we could adapt this theory for all the cancers but the adaptation seems logical. The normal cell is turning itself to a cell, that will no longer be suffering from the inflammation, from environment or etc...When the change starts the normal cell signals no longer can affect the cell or they affect in a way that is inefficient.
We still do not know exactly whether normal cell turns to cancer cell, to cancer stem cell(csc). Or at first it turns to cancer cell then the cancer makes its own csc. I think it is also an adaptation to make cscs, because they can regenerate the cancer tissue from the beginning. So it will never die.
And if we go from another way, I mean if normal cell returns to stem cell (a pathway that allows cell to turn into any other cell), then this stem cell makes cscs and cscs make the cancer tissue.
In both ways, the mechanisms that cancer is using is logical. So maybe the normal cell signals can not affect the cancer cell, but we can not say they are free from signals. Because when we think cancer tissue as an organ then it seems like it is designing its own signal pathways especially with cscs. As far as I remember even the metastatic tissue is connected with the main cancer tissue and if you make something on cancer tissue the metastatic tissue modifies itself. So in a way that we dont understand very clearly, there are signals between cancer cells.
Please correct me if I say something inappropriate...thanks
Well, if we think cancer within our body and normal cells then everything seems chaotic; but if we think cancer as an organ or as an organism independent i think we could discover many unknowns about cancer...at least maybe it could help us for better understanding the cancer.
I think maybe in the article(Epistemology of the origin of cancer: a new
paradigm) Prof. Brücher mentioned adaptation with Chronic-Stress-Escape-
Strategy .
as far as communication between cancer cells is concerned the kisspeptins were first discovered as a matastatic suppressive receptor the gpr54 and same for prokineticins and a lot of therapies are currently being designed with modificationd in kisspeptins along with prokineticins like in prostatic cancer tak some number and further lot of research is going on developing micro RNAs which can help preventing proliferation sat miR 145 IN BREAST CANCER nmiR 122 IN HEPATCELLULAR CANCER AND RECENTLY WITH USE OF M6 methionine transferase miRNAS are being thought of using to convert cells bavck to pluripotent stem cells and utilize as strategies for treating ca and just read role of oncocers a new marker for cancers with the use of sponging miRNAs SO IT IS VERY DIFFICULTTO UNDERSTAND what signals cancer ce;ls use although tumor suppressor genes are suppose to be in control till the balance goes out of order but what decides that a particular infection the immune syatem cant fight and this cancer niche gets out of hand and where it started are some peplexing questions.
Please find below strong evidence supporting the new cancer hypothesis:
Japanese scientists treat lung cancer patients with anti-inflammatory and –fibrotic atrial natruretic peptide and show that patients have by this lower recurrence rates
Summary:
Interesting approach from Japanese scientists: the authors published in 2011 a paper in which they could show, that circulating tumor cells in pulmonary veins during the manipulation of lung cancer surgery could be a prognostic indicator for early recurrence [Funaki et al. Eur J Cardiothorac Surg 2011;40(2):322–327]. Further this group showed, that ANP downregulates inflammatory response and having a prophylactic effect on postoperative complications due to lung surgery [Njiri et al. J Thorac Cardiovasc Surg 2012; 143(2): 488–494 Nojiri et al. Eur J Cardiothorac Surg 2013; 44(1):98–103; Eur J Cardiothorac Surg 2012; 41(6):1330–1334]. It is important to mention that ANP - besides an inhibition of the renin-angiotesin-aldosteron path through specific binding to the guanylyl cyclase-A (GC-A) receptor - has an anti-fibrotic effect (!) [Li et al. Curr Cardiol Rev 2001; 5(1):45–51 and Kishimoto et al. Curr Cardiol Rev 2009; 5(1):45–51]. Now the authors combined these findings and applicated ANP during curative lung cancer surgery and found that the recurrence rate (versus control) was lower.
Nojiri T et al.: Atrial natriuretic peptide prevents cancer metastasis through vascularendothelial cells. Proc Natl Acad Sci U S A. 2015 Mar 16. pii: 201417273. [Epub ahead of print]
http://www.pnas.org/content/112/13/4086.abstract.html?etoc
Independent of the support of the recent published new cancer paradigm:
“Epistemology of the Origin of Cancer: a new paradigm"
BMC Cancer 2014; 14:331: 1-8:
http://www.biomedcentral.com/1471-2407/14/331
and its its deeper explanations by
“Cell-Cell Communication in the Tumor Microenvironment, Carcinogenesis, and Anticancer Treatment"
Cell Physiol Biochem 2014; 34: 213-243
http://www.karger.com/Article/FullText/362978
this could be a very useful approach for future peri-operative application in cancer surgery
- and that is the reason why we are here for.
http://www.pnas.org/content/112/13/4086.abstract.html?etoc
reading this suddenly it comes to mind that in obesity incidence of cancer is very high and ANP has been found to have a correlation with brown adipogenesis,besides obesity is also associated with altered immune system and inflammation with changes in alltype of lymphocytes,,MACROPHAGES,MONOCYTES infilltration in adipocytes and allthese diseases seem to have a corelation basically with inflammation and altered immune system ultimately and answers are being sought even in treating obesity by changing the profile within adipocytes and type of inflammation besides types of adipocytes by increasing ANP BNP system etc although BrCA1 has an indirectcorelation with lipogenesis as well although attributed as a breast cancer gene but plays a big role in altering lipid metabolism s the two are absolutely interrelated..
Thanks, good point, but please have in mind, that obesity in general is "associated with inflammation" (besides without needing a mutation *laugh*)
But then as you said we dont need a mutation laugh for the carcinogenesis to begin and it is only the niche in the inflammatory area which becomes precancerous and hence doing away with the somatic mutation theory.
The following attached paper [Kim et al. Pancreas 2015 Apr 18] reveals
http://journals.lww.com/pancreasjournal/Abstract/publishahead/The_Basic_Helix_Loop_Helix_Transcription_Factor.99027.aspx
(1)
Huge evidence that the recent proposed “NORMAL CELL – CANCER CELL TRANSITION (NCCCT)” in “Epistemology of the origin of cancer: a new paradigm” at BMC Cancer 2014;14(331):1-15 is real
(2)
CANCER CELL TRANSITION can be reversed to NORMAL CELL and
(3)
It s unlikely that mutations are evolved in the development as the reverse does not affect such.
http://journals.lww.com/pancreasjournal/Abstract/publishahead/The_Basic_Helix_Loop_Helix_Transcription_Factor.99027.aspx
http://www.biomedcentral.com/content/pdf/1471-2407-14-331.pdf
the following may be of relevance:
Prostate primary human basal and luminal epithelial cells are cells of origin of cancer / PNAS 2016
https://www.linkedin.com/groups/1884710/1884710-6123387419854200835
Park et al. PNAS 2016:
http://www.pnas.org/content/pnas/early/2016/04/01/1603645113.abstract.html?collection
Abstract
The cell of origin for prostate cancer remains a subject of debate. Genetically engineered mouse models have demonstrated that both basal and luminal cells can serve as cells of origin for prostate cancer. Using a human prostate regeneration and transformation assay, our group previously demonstrated that basal cells can serve as efficient targets for transformation. Recently, a subpopulation of multipotent human luminal cells defined by CD26 expression that retains progenitor activity in a defined organoid culture was identified. We transduced primary human prostate basal and luminal cells with lentiviruses expressing c-Myc and activated AKT1 (myristoylated AKT1 or myrAKT1) to mimic the MYC amplification and PTEN loss commonly detected in human prostate cancer. These cells were propagated in organoid culture before being transplanted into immunodeficient mice. We found that c-Myc/myrAKT1–transduced luminal xenografts exhibited histological features of well-differentiated acinar adenocarcinoma, with strong androgen receptor (AR) and prostate-specific antigen (PSA) expression. In contrast, c-Myc/myrAKT1–transduced basal xenografts were histologically more aggressive, with a loss of acinar structures and low/absent AR and PSA expression. Our findings imply that distinct subtypes of prostate cancer may arise from luminal and basal epithelial cell types subjected to the same oncogenic insults. This study provides a platform for the functional evaluation of oncogenes in basal and luminal epithelial populations of the human prostate. Tumors derived in this fashion with defined genetics can be used in the preclinical development of targeted therapeutics.
https://www.linkedin.com/groups/1884710/1884710-6123387419854200835
yeap, very true, for this it is necessary reading the Content of the papers provided in detail, best regards
Someone may be interested reading carefully the commentary written commentary by Dr. Stuart G. Baker, National Cancer Institute, Bethesda, MD, USA, which was brought up by Ijaz:
“The questionable premises underlying the search for cancer driver mutations and cancer susceptibility genes.”
Dr. Stuart G. Baker, National Cancer Institute, Bethesda, MD, USA
http://www.cognitivephilology.uniroma1.it/index.php/Organisms/article/view/13873/13628
http://www.cognitivephilology.uniroma1.it/index.php/Organisms/article/view/13873/13628
As proposed in BMC Cancer 2014, 14, 331.
DOI: 10.1186/1471-2407-14-331
Stimulation TNF-α plus TGF-β1 downregulates E‑cadherin & promote Cell Transition via NF‑κB path / Li et al. Oncol Letters 2018
Article Simultaneous stimulation with tumor necrosis factor-α and tr...
Thanks for having shared this new and important work, Bjorn. The implication that conversion of proto-oncogenes to oncogenes plays a role in oncogenesis as in "Our findings imply that distinct subtypes of prostate cancer may arise from luminal and basal epithelial cell types subjected to the same oncogenic insults." The initial lesion is supported by work in the field.
Kind regards,
Ferez
Precancerous niche (PCN) with its remodeled fibrosis predicts immunotherapy response / Chakravarthy at al. Nat Com 2018
https://www.nature.com/articles/s41467-018-06654-8
It seems scientists start to recognize the significance of the precancerous niche which was originary published in BMC Cancer 2014 :
https://www.researchgate.net/publication/262215307_Epistemology_of_the_origin_of_cancer_A_new_paradigm
Agree that cellular transitions are common and inflammation is a major mechanism in carcinogenesis. I see cancer as an emergent system, arising from normal functional tissue units.
See https://www.frontiersin.org/articles/10.3389/fonc.2017.00198/full
and Thesis Emergence and Margins in Head and Neck Cancer: A new understanding
#StayTuned
- next week 4open by EDP Sciences will release the first peer-reviewed papers of an expensive Special Issue dealing with "carcinogenesis" consisting of
-pathogenic stimuli
-chronic inflammation
-fibrosis with its
-remodeling into precancerous niche PCN plus
-eicosanoids
-ubiquitous proteins
-microbiome
-morbid obesity
-metformin
Thanks to our great Guest Editor Obul Reddy Bandapalli - great work !
Happy Easter around the Globe with Peace and Happyness !
https://www.youtube.com/watch?v=IPg_W8VJdqE
Ijaz S. Jamall
Obul Reddy Bandapalli
In case of interest:
4open: Special issue first 7 out of 10 papers are out
Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer”
Obul R. Bandapalli (Guest Editor) - DKFZ Heidelberg, Germany
KEY SUMMARIES https://www.4open-sciences.org/key-summaries/306-new-research-challenges-current-thinking-on-cancer
Ijaz S. Jamall
Dear Björn,
Congratulations to your findings on the possible role of epithelial mesenchimal transition in cancer superparasitism.
The 8th out of 10 papers dealing with carcinogenesis is out:
NF-κB signaling and crosstalk during carcinogenesis
https://www.4open-sciences.org/articles/fopen/full_html/2019/01/fopen180043/fopen180043.html
Ijaz S. Jamall and @Florian Lang
Maybe something to think:
In vitro: antibacterial salinomycin decrease cancer cell growth, proliferation and metastasis in CDDP resistant breast cancer cells via NF-kB deregulation / Tyagi and Patro in Toxicol In Vitro 2019
https://www.sciencedirect.com/science/article/pii/S0887233319300347
#StayTuned
soon the 9th costly paper entitled
"Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress "
of the 4open Special Issue
Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer”
https://www.4open-sciences.org/component/toc/?task=topic&id=1080 will be released
Ijaz S. Jamall
9th out of 10 papers is out
Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress
https://www.4open-sciences.org/articles/fopen/full_html/2019/01/fopen180010/fopen180010.html
Ijaz S. Jamall
Thank you Gene Levinson for your outstanding independent judgement as a recognized molecular geneticist scientist
We are deeply humbled
https://bit.ly/2Vyplll
Interesting that we since some 100 years – from the very courageous proposals “for that time” by Boveri (1914) and Bauer (1928) – still - in accordance to Vogelstein and the Biotech branch (proposers of the Mutation dogma) - search for mutations. We may ask ourselves: who – in this case - has the most benefit from it? –patients?
We may continue to drive a blind alley – but this increasingly gets an ethical (and not just a scientific) question – and each cancer scientists in the near future will be judged by it by the public.
Attached the newest (frightening) data of consistently increase of CRC incidence in young patients - reality hurts:
Europe
COLON RECTAL Cancer 'consistently' rises among young European Adults aged 20–29 years AND aged 30–39 and 40–49 years / BMJ 2019
https://gut.bmj.com/content/early/2019/04/16/gutjnl-2018-317592
USA
CRC among US adults < 50 y (with greatest increase in cM1-disease) increased with 2.9% increase per year / JAMA 2019
https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.3076
If riding on horses does not work, maybe riding on a tiger or an elephant?
Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation / Lee et al. Science 2019
https://science.sciencemag.org/content/363/6427/644.long
The findings are in accordance to
(1)
https://bit.ly/2JcpGaL and
(2)
https://bit.ly/2J3CUGZ published in
@4open by @EDP_Sciences
Attached the modified illustration in accordance to Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer”
Alternative fatty acid desaturation pathway independent from SCD1 / Vriens et al. Nature 2019
Article Evidence for an alternative fatty acid desaturation pathway ...
The findings are in accordance to
(1)
https://bit.ly/2JcpGaL and
(2)
https://bit.ly/2J3CUGZ
published in @4open by @EDP_Sciences
Attached the modified illustration in accordance to Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer”
"Mutant BRCA is an indispensable founding event for 'some' tumours, but in a considerable proportion of other cancers, it appears to be biologically neutral"
Jonsson et al. Nature 2019
https://www.nature.com/articles/s41586-019-1382-1
Mice with abrupt involution induce chronic inflammation, fibrosis, remodeling (which someone may call Precancerous Niche) followed by ductal hyperplasia and metaplasia and cancer
Basree et al. Breast Cancer Rev 2019
https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-019-1163-7
Increasing Evidence for cancer paradigm “Epistemology of the Origin of Cancer”
https://bit.ly/2IW7Icx
https://bit.ly/2LavqnP
Cancer development is always follows the first law of themodynamics based on metastable (Fröhlich) states via increased membrane polarization (J.Molnar et at al, Letters in Drug design and Discovery 2/6, 429-439, 2005.
Various variables such as environment, temperature, ion channels, etc. influence membrane polarization which itself (at least to me) does not explain so far how carcinogenesis develops.
You are right.
The qustion is much more complex the number of papers will explain more details
It seems Joseph you have not read the provided literature - of course I can be wrong.
"increased membrane polarization" - it is result (not reason) of cancer development.
The reason for cancer transformation and then cancer development is destabilization/dysregulation of positive feedback for ATP
I have described this phenomenon is my article: Article Bioenergetics of life, disease and death phenomena
Thanks, Andrzej for your insights.
I as many others disagree. We really highly appreciate and recognize Warburg's contribution 1923-1925.
For understanding these insights, as you suggested, I may be allowed to highly recommend reading the original literature in this regard prior to Warburg starting 1789 by Seguin et al followed by Rubner et al. starting at 1893, which clearly explains the physiology and its metabolism.
This clearly reveals, that it cannot be the destabilization/dysregulation of positive feedback for ATP.
Furthermore, you state in your paper, that due to this, mutations are necessary, which (I apologize again) is also wrong, as it had been provided during the last decade that this is not necessary - despite the some 5-to-10% of cancers in which it is an indispensable condition.
Soon the last paper of the Special Issue will be available which will provide also the mentioned literature in detail.
I apologize.
no need getting distanced by using titles - we are all just humans, nothing else
just saying, as these points had all not been adressed in your provided paper but which may be of significant relevance despite also additionally some anthropology scienctific papers plus research in drosophila and flat worms
e.g.such as posted (comprehensed) here entitled "myths vs facts":
https://www.linkedin.com/pulse/free-radicals-bad-your-health-myths-reality-prof-of-surgery/
thanks
have a nice sunday
best
björn
Something to think - maybe even to re-think
Genomic variability with Aneuploidy often physiological (not pathogenic)
Spectral karyotype analysis reveals ≈33% of neuroblasts as aneuploid
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC60876/
Dear Björn,
Thank you for your support.
In my article I deal with unified cell bioenergetics (UCB) - for this reason in this article I have written only about what is visible from the perspective of UCB. So, I know these problems you mentioned, but not all phenomena that occur during cancer development are possible to interpret using UCB.
best wishes,
Andrzej
Thank you Andrzej
As (unfortunately) seen you have not read the provided literature - otherwise you would have not made that statement
Again, i apologize
Best björn
Please allow me to provide another point which (from my perspective) may be even of high significance in this regard:
We know – although many might not being aware – that in case someone analyzes databases, that a recent simulation database trial of Multiple Sclerosis (MS) patients revealed, that the percentage of false positive findings can exceed 20%, depending on variable selection [BMC Medical Research Methodology 2008, 8, 18, DOI: 10.1186/1471-2288-8-18 ]. Besides: Martin Daumer’s research led to the fact, that MRT for predicting MS (which was during that time a dogma) was cancelled.
Meaning for here:
At least “that” potential false bias (knowing the paradigm) was here not available, as the distinguished scientists of Breast Cancer Res 2019 proved our paradigm independently from us ‘without’ being aware about our paradigm (but of course of their own results) [as you can see, it was not cited]:
https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-019-1163-7
However, at this potential bias was ‘not’ existing. This may even be of significance.
Dear Björn,
in this sentence: "support = help with understanding".
best wishes,
Andrzej
Dear Andrezej,
thank you - I am sure, you will appreciate the until now missing last paper of the Special Issue as many aspects will be extensively provided.
I would guess we have a huge challenge in science these days as provided in the 1st Editorial of 4open: the mass of scientists do not read anymore the primary literature or /and even does not cite it - meaning content ('something') of our prior giants in medicine and science is not thought through as they did it (not with the reflection as needed) and the domino effect takes place, but here with (often) wrong secondary interpretation.
I would love working with you in this field but by now are packed with all papers which at the end of 2014 were started but had to be interrupted due to family reasons - therefore this takes another couple of months getting all those finalized as here collaborative colleagues from abroad still wait for them for what I have a bad conscience all the time since.
thank you again
best björn
Dear Björn,
I wish you all the best, and I'll read your Special Issue with interest keeping my fingers crossed. Regarding cooperation - of course with great pleasure.
best regards,
Andrzej
Last (missing) paper of Special Issue finalized and re-submitted with
-n=5 Figures
-n=355 References
Björn L.D.M. Brücher
in line with your definition (EMT, embryogenesis, morphogenesis ), I would like to share my idea simple and vividly;
let's review the cell, tissue, and organism whole scenario. at first, there is a cell with goddess power to make all kind of tissue but after a few steps, it got compromised at some levels (we call it differentiation). maybe, the concept of question is different; because being stem/cancer-like is sort of default. So adult cells in the face of situation/ damage or (partially) unknown phenomenon turn back to the default form.
The following may be of relevance in this regard:
"Even epithelial mesenchymal transition (EMT) itself can induce non-cancer stem cells to become stem cells" [Mani Cell 2008; Morel PLoS One 2008].
The suggestion that “mutator phenotype” in terms of stem cells would explain how a large number of mutations could possibly be generated [Wogan Semin Cancer Biol 2004] was proven to be incorrect [here see Jonsson Nature 2019, DOI: 10.1038/s41586-019-1382-1].
Fascinating. This is probably naive, but what about those tumor marquers that reflect tumor gene mutations, such as the Philadelphia chromosome? Are they interpreted as being secondary? But then, how to interpret the role of heredity (e.g. BRCA1/2 related breast cancer)?
Thank you Miguel,
- we clearly state that there is a difference between those 5-to-10% of cancers which are proven being orignated by germline mutations and which we do not question.
I apologize for the complexity below:
However, in regard to the mass of cancers, we prefer a very differentiated view in this regard, which explains why we on purpose published n=5 peer-reviewed papers together with the cancer paradigm 2014-2016. [peer-review process duration: 8 months]
1. (2014), Epistemology of the origin of cancer: a new paradigm, BMC Cancer 14(186), 1-15.
Article Epistemology of the origin of cancer: A new paradigm
2. (2014), Cell-Cell communication in tumor microenvironment, carcinogenesis and anticancer treatment, Cell Physiol Biochem 34(2), 213-243.
Article Cell-Cell Communication in the Tumor Microenvironment, Carci...
3. (2014), Imagine a World without Cancer, BMC Cancer 14(186), 1-8.
Article Imagine a world without cancer.
4. (2016), Somatic Mutation Theory: Why it’s Wrong for Most Cancers, Cell Physiol Biochem 38(5), 1-18.
Article Somatic Mutation Theory - Why it's Wrong for Most Cancers
5. (2016), Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response n upper GI cancers, Clin Transl Med 5, 1-16.
Article Genomics, microRNA, epigenetics, and proteomics for future d...
Afterwards we published (after peer-review of course) twthe Evidence of the 2014 cancer paradigm within a Special Issue recently 20 [peer-review process duration 12 months]19
(1 paper, “Synopsis” will come up shortly)
1. (2019), Key Summaries Special Issue: Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer”
https://www.4open-sciences.org/key-summaries/306-new-research-challenges-current-thinking-on-cancer
2. (2019), Prelude and Premise to the Special Issue, 4open 2(6), 1-8.
Article Prelude and premise to the special issue: disruption of home...
3. (2019), Undervalued ubiquitous proteins, 4open 2(7), 1-13.
Article Undervalued ubiquitous proteins
4. (2019), Chronic inflammation evoked by pathogenic stimulus during carcinogenesis, 4open 2(8), 1-22.
Article Chronic inflammation evoked by pathogenic stimulus during ca...
5. (2019), Eicosanoids in carcinogenesis, 4open 2(9), 1-34. https://bit.ly/2yqbg0o.
Article Eicosanoids in carcinogenesis
6. (2019), Microbiome and morbid obesity increase pathogenic stimulus diversity, 4open 2(10), 1- 16.
Article Microbiome and morbid obesity increase pathogenic stimulus diversity
7. (2019), Precancerous niche (PCN), a product of fibrosis with remodeling by incessant chronic inflammation, 4open 2(11), 1-21.
Article Precancerous niche (PCN), a product of fibrosis with remodel...
8. (2019), Metformin alters signaling homeostasis, 4open 2(12), 1-17.
Article Metformin alters signaling induced crosstalk and homeostasis...
9. (2019), NF-κB signaling and crosstalk in carcinogenesis, 4open 2(13), 1-35.
Article NF-kB signaling and crosstalk during carcinogenesis
10. (2019), Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress, 4open 2(14), 1-31.
Article Transition from normal to cancerous cell by precancerous nic...
Afterwards, the complexity of the 2014 peer-reviewed published cancer paradigm was now independently from us proven here "Breast Cancer Research, Volume 21, Article number: 80 (2019)"
Again Miguel, I apologize for the complexity above, but from our perspective it is necessary. thanks björn
thanks to Ijaz S. Jamall for this piece
Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
/ Long et al. Nat Microbiol 2019
https://www.nature.com/articles/s41564-019-0541-3
in this regard
Chronic inflammation evoked by pathogenic stimulus during carcinogenesis
https://bit.ly/2YfZV22
Microbiome and morbid obesity increase pathogenic stimulus diversity
https://bit.ly/2YxxpEC
NF-κB signaling and crosstalk during carcinogenesis
https://bit.ly/2SONi8c
In case of this may be of interest, the last (missing) paper is out
Synopsis: Special Issue on “Disruption of signaling homeostasis induced crosstalk in the carcinogenesis paradigm Epistemology of the origin of cancer”
4open 2(28), 1-30.
https://www.4open-sciences.org/articles/fopen/full_html/2019/01/fopen180008/fopen180008.html
The following may be of interest (some may call it disruption of homeostasis)
Endoscopically healed mucosa of ulcerative colitis (=precancerous condition) show persisting dysregulation in regard to cytokines, fibrosis-associated mediators
/ Gundersen et al. Clin Transl Gastroenterol 2019
https://bit.ly/30Pb2LS
Value of Genes triggering carcinogenesis due to familial risk in CRC had been overestimated
Weigl et al. Int J Cancer 2019 - DKFZ, Heidelberg, Germany
Until now, cancer centers worldwide overestimated (and still do) the value of genes in causing carcinogenesis.
The DKFZ in Heidelberg, Germany, starts now - as one of the (very) rare leading cancer centers in the world - to face reality in saying goodbye to these 'believes':
Familial risk in CRC by single nucleotide polymorphisms (SNPs) is 10% less:
between 5.4 -14.3%
Someone may look in detail about the HR with its 95% CI values
https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32664
Attached the press release:
https://www.dkfz.de/en/presse/pressemitteilungen/2019/dkfz-pm-19-42-Familial-risk-of-colorectal-cancer-the-genes-only-tell-part-of-the-story.php
“…scientists …. conclude that the role of genes has been overestimated in patients with a higher familial risk of colorectal cancer..”
Maybe (hopefully) the time is right now, being proud enough to face reality and getting away from hypes, wishes, and believes
Although reality sometimes hurts
This means that the from some scientists felt heretical declaration of the reality in our paper in regard to SMT in 2016 of my distinguished coauthor and friend Ijaz S. Jamall and me was correct.
https://www.researchgate.net/publication/301787378_Somatic_Mutation_Theory_-_Why_it's_Wrong_for_Most_Cancers
CD95 activation in single cancer cells leads to apoptosis while in the composite (e.g. solid tumors) results into growth stimulus
Balta et al. Cell Rep 2019
Highlights
• Specific intermolecular spacing of CD95Ligand induces efficient CD95 clustering
• CD95 clustering triggers apoptotic and survival signaling
• CD95 signals survival in the presence of cell-cell contact
• Cell-cell contact increases levels of phosphotyrosinated proteins including CD95
Article 3D Cellular Architecture Modulates Tyrosine Kinase Activity,...
Spectral karyotype analysis reveals ≈33% of neuroblasts as aneuploid
Rehen et al. PNAS 2001
Genomic variability with aneuploidy often physiological (not pathogenic)
Something to think - maybe even to r e-think
https://www.pnas.org/content/98/23/13361.long
Where are now all these market barker's?
- who propagated it for more than two decades and
- due to it so many women underwent
- uncessearily mutilation by mastectomies?
Society faces the catastrophal reality about the stupid primary odds ratio's which led to it's horrible and stupid consequences
https://www.wsj.com/articles/seven-women-in-a-family-chose-surgery-after-a-genetic-test-then-the-results-changed-11576860210
We anticipated in 2014 that this day would come, that
https://www.researchgate.net/publication/301787378_Somatic_Mutation_Theory_-_Why_it%27s_Wrong_for_Most_Cancers
Hopefully thinking with re-thinking will increase at least here in this regard 'now'
Cancer cells spread using a copper-binding protein
Someone may start “thinking” about this piece as it is important
Lysyl Oxidase is a Copper-dependent enzyme and major key enzyme during sequence #3 in carcinogenesis (first onset of a cancer cell)
What does this tell you?
https://www.chalmers.se/en/departments/bio/news/Pages/Cancer-cells-spread-using-a-copper-binding-protein.aspx
I am not a medical doctor, but from reading your question, it sounds like that people should avoid chronic injury to minimize a chance of getting cancer. Regarding the cancer, what I learned throughout my life experience is that cancer cell is nothing more than our own cell that refuses to follow the orders from authority. It objectives is to spread and multiply. It acts like stem cell in similar fashion. To grow it needs a building block that contains nitrogen just like healthy cell. To get that, it goes to lymphatic nodes were nitrogen (in organic form) is produced. This information is based on Gaston Naessens work albeit heretic even today.
Think // Re-Think
Transgenic BAC-Sprr2f-Cre model / Cuevas PNAS 2019
Knockdown of
(1) tumor suppressor Fbxw7 (CDC4) together with
(2) Phosphatase and tensin homolog (PTEN) resulted into
-increased cell transition with
-consequent precancerous lesions (endometrioid intraepithelial neoplasia) and
-well-differentiated endometrioid adenocarcinomas
-which progressed within 12 and 48 weeks to biphasic carcinosarcoma
Something to think about:
-Contrary to earlier reports p53 mutations (associations in advanced cancer cases)
-was NOT not detected in mouse uteri at 12 weeks (early) in cancer or normal endometrium,
-p53 clonal overexpression increased over time, reaching 80% in mice euthanized due to illness per tumor burden criteria.
https://www.pnas.org/content/116/51/25880
Interesting
However, before i would use this usually nearly automatic explanation of genome re-organisation, i always look carefully for the Physiology, pathophysiology and biochemistry
Gastric Cancer YOUNG Patients - and Epstein-Barr Virus
EBNA3
-strain B95-8
-HHV-4
-Human herpesvirus 4
Moore et al. BMC Cancer 2020
Conclusion:
Our study indicates that EBV subtype is more prevalent in young-onset GC and may play a key role in the pathogenesis.
https://bit.ly/3d7SOw2
Important for understanding Precancerous Niche (PCN) / Signaling during carcinogenesis
PLUS another explanation why irradiation secondary induces its own additional PCN
Guot et al. Biochem Biophys Res Commun 2020
Irradiation
-activates IKKβ/NFκB
-enhances transcription & synthesis of LOX
siRNA knockdown IKKβ largely abolished LOX production
Triptolide (TPL) - in general -
-diterpenoid with 3 epoxide groups
-inhibits inflammation (TNF-α, MAP kinases, IL-2, etc)
-anti-cancer / -leukemia effects in animal models (mice, dogs)
Triptolide (TPL) - here -
-prevents NFκB nuclear translocation & DNA binding
-inhibition of IKKβ/NFκB pathway which
-decreases LOX synthesis
By this, TPL alleviates Radiation-Induced Pulmonary Fibrosis
https://bit.ly/3escuv3
Intra-Tumor- and Immune-cellular bacteria
Pathogenic stimulus?
Neijman et al. Science 2020
https://science.sciencemag.org/content/368/6494/973
9190 bacterial species across different tumor or normal tissue types
Average of 16.4 bacterial species in any single breast tumor sample, vs
Maybe of relevance
New research challenges current thinking on cancer
Disruption of homeostasis-induced signaling & crosstalk in the carcinogenesis paradigm "Epistemology of the origin of cancer"
https://bit.ly/2McSyjM
As it is complex, some scientists wrote me by email asking to provide step-by-step explanation if evidence undermine the multi-step carcinogenesis paradigm 'Epistemology of the origin of cancer'
thank you again, for this valuable advice which is implemented within the following example
-although is getting difficult do justice about it, as every single week between 2-to-4 papers in this regard come out - but I still try keeping you update
1 / 4
Abstract AACR 2020 / John-Hopkins
"Among over 10,000 epithelial ovarian cancer pts, those that used any type of statin had a
-40% reduction in ovarian cancer mortality vs with never-users (HR 0.60, 95% CI 0.54-0.66) and a
-37% reduction 5-y mortality (HR 0.63, 95% CI 0.56-0.70)
Source Reference:
Visvanathan K, et al "Lipophilic statins show promise for treatment of epithelial ovarian cancer" AACR 2020; Abstract 5782
https://www.abstractsonline.com/pp8/#!/9045/presentation/5297
2 / 4
Statins
-decrease cholesterin &
plus inflammation plus fibrosis
[literature can be provided if needed]
also through TGF-beta independent signaling paths e.g. via YAP
See Synopsis Paper Special Issue 2019
Figure 2 (YAP)
https://www.4open-sciences.org/articles/fopen/full_html/2019/01/fopen180008/fopen180008.html
3 / 4
independent additional
indirect prove of "Epistemology of the origin of cancer"
4 / 4
All Anti-cancer trials with
-Chemo
-Immunochemo
with a difference in
-Overall Survival and / or
-Progression free survival
-of some 2-to-12 months
need re-analysis providing the proportions of pts in trials who received statins (here lipohilic statins), metformin, ASS, etc.
otherwise effect might be attributed to a drug within a trial, which may should be attributed to a different mechanism
FOXO3a suppresses
-DNA double-strand break-induced mutations,
-genome instability and
-genome rearrangements
White et al. Aging Cell 2020
https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13184
In this regard
The following might be of interest – please see Fig.1 / FOXO3a
https://www.4open-sciences.org/articles/fopen/full_html/2019/01/fopen180014/F1.html
Lysyl Oxidase (LOX) and LOXL2 Inhibitors reduce cancer growth - in a spontaneous breast cancer genetically engineered mouse model -Smithen et al. J Med Chem 2020 -DOI: 10.1021/acs.jmedchem.9b01112 Article 2-Aminomethylene-5-Sulfonylthiazole Inhibitors of Lysyl Oxid... #peerreviewed # for actual @JMedChem #findings may be of relevance 2014 "Epistemology of the origin of cancer: a new paradigm" BMC Cancer 14(186) 1-15.
4open special issue presents a new paradigm for cancer (n=10 papers)
https://www.4open-sciences.org/key-summaries/306-new-research-challenges-current-thinking-on-cancer
here as well
PARP and Immune Checkpoint Inhibition in Ovarian Cancer
https://www.cell.com/trends/cancer/fulltext/S2405-8033(19)30123-2?
Here as well - the following may serve as the basis for the findings of the distinguished authors
(1)
4open special issue presents a new paradigm for cancer
https://www.4open-sciences.org/key-summaries/306-new-research-challenges-current-thinking-on-cancer
esp here see the paper synopsis / figure attached
https://www.researchgate.net/publication/336148329_Synopsis_Special_Issue_on_Disruption_of_signaling_homeostasis_induced_crosstalk_in_the_carcinogenesis_paradigm_Epistemology_of_the_origin_of_cancer
Based on
(2)
Article Epistemology of the origin of cancer: A new paradigm
Article Cell-Cell Communication in the Tumor Microenvironment, Carci...
LOXL1 decreases CRC cancer progression by inhibiting the transcriptional activity of YAP
Hu et al. Cell Commun Signal 2020
https://biosignaling.biomedcentral.com/articles/10.1186/s12964-020-00639-1
This is concordant to
(1)
Decreasing LOXL1 arrests fibrosis as crosslinking of elastin is reduced
[Zhao et al. Biochim Biophys Acta Mol Basis Dis 2018 – so far no PubPeer comment]
(2)
Necessary differentiated view on LOX iso-enzymes
(3)
Plus
in regard of CXCR4 and #YAP #FADS2 etc
Figure 1 & 2 of the following paper may be of relevance as well
https://bit.ly/33Y8Iro
#carcinogenesis #cancer
#TGFβ #SNAIL #ZEB #TWIST #RAS #MAPK #SMAD #RREB1 triggers #fibrosis plus #cell #transition
Su et al. Nature 2020
https://www.nature.com/articles/s41586-019-1897-5
Another prove of „Epistemology of the origin of cancer” which serves as basic for actual findings
Further reading here
2014 https://bit.ly/31UGI6z
2019 Special Issue #Key #Summaries
https://bit.ly/2DodvHs
Ijaz S. Jamall
Dear Mesut
as discussed earlier
If you have read what provided in detail
you find both
-how and
-why
best
björn
Periodontal pathogens promote cancer in OSCC via TLR/MyD88 and Integrin/FAK crosstalk inhibited by Nisin (polycyclic peptid by Lactococcus lactis)
Kamarajan et al. PLoS Pathog 2020
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008881
Earlier findings as #basics for actual findings may be of relevance in regard of FAK / TLR signaling during the multistep signaling process of carcinogenesis
(1)
(2014) Cell-Cell communication in tumor microenvironment, carcinogenesis and anticancer treatment, Cell Physiol Biochem 34(2), 213-243.
https://www.researchgate.net/publication/263779633
(2)
(2019) Undervalued ubiquitous proteins, 4open 2(7), 1-13.
https://www.researchgate.net/publication/332631177
And
(3)
(2019) Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress, 4open 2(14), 1-31.
https://www.researchgate.net/publication/333131780
Larger organ size caused by obesity mechanism for higher cancer risk / Tomasetti et al. BioRxiv 2020 (web link below)
https://www.biorxiv.org/content/10.1101/2020.07.27.223529v1.full#
Summary
(1) No logic of the smaller the better.
(2) Statistical associations are (again) wrongly interpreted as being causative
(3) Common Sense should be used & teached again
Explanation
(1) Scientists ignored completely > 120 y of physiology & pathophysiology research
(2) Persistent attempt is made to bend an interpretation into a biased direction - try to justify assumptions (made earlier on basis of higher cell count & division)
(3) Humans
-26 y rates increased in all investigated countries irrespective of age by 22%
[Rizzi et al. (2020) Ann Epidemiol – DOI 10.1016/j.annepidem.2020.04.007]
-other vertebrate species
low rates such 0.2% in Canada geese vs > 50% in Santa Catalina Island foxes & Cape mountain zebras
[Abu-Helil (2019) Clin Exp Metas - DOI 10.1007/s10585-019-09956-3]
(4) Softshell clams:
22% neoplasms & 40% metastasis
[Abu-Helil (2019) Clin Exp Metas - DOI 10.1007/s10585-019-09956-3]
(5) If someone does not accept logic, take the following:
Graphs misinterpreted
- too few data on right hand side
- just cluster on left
- zero correlation
Conclusion:
Thinking maybe of higher value and importance than trying hard (ab)using maths to fit into believes and assumptions, especially as these already failed earlier.
#cancer #obesity #organs #carcinogenesis
Ijaz S. Jamall
Maybe something which should be thought about – plus explanation:
1/2
The distinguished authors performed a Circulating tumour DNA analysis to direct therapy in advanced breast cancer and it was published in Lancet Oncology
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30444-7/fulltext
Here the authors stated
“Our results demonstrate clinically relevant activity of targeted therapies against rare HER2 and AKT1 mutations, confirming these mutations could be targetable for breast cancer treatment.”
No question - the authors provided a nice clean trial but for some 5% of breast cancer pts only (although small numbers), because
Those who are aware about the literature know that their findings affect only some 5% of breast cancer patients
Because the prevalence of the mutations (they highlighted) are
-ESR1
2/2
No question, this is a nice trial plus it provided evidence for some 5% of breast cancer patients
But the Following may be important
Since some 70y we consistently hear & read free DNA would impact decision making plus therapy in cancer
Maybe scientists in general are not confident speaking up as being against the mainstream is less en vogue which may explain why the mass of scientists always keep silent because staying silent is of course much safer
But that should not be the point from my perspective
It is our duty increasing knowledge for science & progress f pts & relatives (mankind)
BUT maybe thinking helps:
-living cells spontaneously release DNA within a homeostatic mechanism
So, how does this fit in as well?
Exemplary short reference list:
Unacknowledged reuse (plagiarism) of original Cancer paradigm · “Epistemology of the origin of cancer” with following papers 2014-2019
by Harvard & Boston University scientists · Hadi T Nia, Lance L Munn, Rakesh K Jain · in Physical traits of cancer at Science 2020
· DOI 10.1126/science.aaz0868
#Scientists should make up their own mind
1 Make 3-step check and see the obvious (see figures attached)
2 Read Letter (peer-reviewed by independent scientists & approved)
https://bit.ly/32GHUKv
3 Read short expose (peer-reviewed by independent scientists & approved)
https://bit.ly/35rbIN6
Transparent & publicly
SUGGESTION To facilitate independent judgment, we recommend reading in the following order:
2014-2016 1 DOI 10.1186/1471-2407-14-331 2 DOI 10.1159/000362978 3 DOI 10.1186/1471-2407-14-186 4 DOI 10.1186/s40169-016-0093-6 5 DOI 10.1159/000443106
2019 6 DOI 10.1051/fopen/2019005 7 DOI 10.1051/fopen/2019002 8 DOI 10.1051/fopen/2018006 9 DOI 10.1051/fopen/2018008 10 DOI 10.1051/fopen/2018007 11 DOI 10.1051/fopen/2018009 12 DOI 10.1051/fopen/2019006 13 DOI 10.1051/fopen/2019010 14 DOI 10.1051/fopen/2018996 15 DOI 10.1051/fopen/2019023
2020 16 DOI 10.1126/science.aaz0868 17 SHORT EXPOSE https://bit.ly/35rbIN6
#science #research #researcharticle #cancer #carcinogenesis #ethics #ethicsmatter #ethicsandcompliance #compliance
Silence is not an option - Anything will be kept transparent and publicly
https://www.linkedin.com/posts/bruecher_scientists-science-research-activity-6732938081986478080-slDO
Transparent & publicly - no-one will be left behind - never
#Scientists make up own mind - #Responsibility & #Leadership just terms?
Content (1) & (2) below "peer-reviewed by various recognized #Editors of various scientific Journals e.g. #Physiologists #Biochemists #Molecular #Biologists #Scientists & approved by each" *All testify anytime*
*Experienced Editors Publishers know what that means*
Files
1 letter
https://bit.ly/36wqGRf
2 expose
https://bit.ly/3eVPh5O
3 debate
https://bit.ly/3lvuEQf
4 think
https://bit.ly/36y3WAt
5 Epistemology of the origin of cancer
https://bit.ly/38OddqV
6 few proofs & recap Spec Issue
https://bit.ly/36w7Fym
Dear Dr Brucher
Then, what is the roll of exercise to low the risk to undergo cáncer??
Example brest cáncer.
Luis
In vitro & vivo liver fibrosis alleviation by 5-MTP
Tong et al. Cell Cycle 2021
DOI: 10.1080/15384101.2021.1897241
5-methoxytryptophan (5-MTP)
· inhibited TGF-β1-induced collagen I, collagen III, fibronectin, aSMA
· increased FOXO3a (! – see comments 1-3 below)
· decreased miR21
· attenuated fibrosis
Abstract
… Here, we investigated anti-fibrotic effects of 5-MTP on liver fibrosis and its underlying mechanism. In vitro, 5-MTP treatment could inhibit TGF-β1-induced elevated levels of collagen I, collagen III, fibronectin and α-smooth muscle actin (SMA) by stimulating autophagy process. Mechanically, the expression of FOXO3a was enhanced by 5-MTP and then repressed the level of miR-21, eventually leading to a restoration of autophagy-related gene ATG5. Furthermore, rescue experiments showed 5-MTP could activate autophagy process and suppress the activation of LX-2 cells by regulating FOXO3a/miR-21/ATG5 pathway. Consistently, 5-MTP significantly attenuated CCl4-induced hepatic fibrosis in rat model. In conclusion, our research discovered that 5-MTP effectively alleviated liver fibrosis in vitro and in vivo, which provided new insights into the application of 5-MTP for liver fibrosis.
https://www.tandfonline.com/doi/abs/10.1080/15384101.2021.1897241?
Some more aspects for a more deeper understanding
(1)
5-methoxytryptophan (5-MTP, C12H14N2O3)
· derives from L-Tryptophan and
o synthesized via tryptophan hydroxylase-1 (TPH-1) and hydroxyindole O-methyltransferase (HIOMT)
· suppresses COX-2 [Chen et al. (2012), PNAS 109, 13231–13236 - DOI: 10.1073/pnas.1209919109]
· inhibits cell transition, cancer cell migration, metastasis [Cheng et al. 2016) Oncotarget 7, 31243–31256 - DOI: 10.18632/oncotarget.9111]
· inhibits PI3k signaling [Fang et al. (2020) Life Sci 260, 118399 - DOI: 10.1016/j.lfs.2020.118399]
· produced in vascular endothelia [Wang et al. (2016) Circ Res 119, 222–236 - DOI: 10.1161/CIRCRESAHA.116.308559]
(2)
as posted here some 8 months ago
FOXO3a suppresses
· DNA double-strand break-induced mutations,
· genome instability and
· genome rearrangements
· White et al. Aging Cell 2020 [DOI: 10.1111/acel.13184]
(3)
Findings above (Tong et al.) in terms of PI3K signaling and FOXO3a homeostasis
· 5-MTP
o inhibits TGF-β1, PI3K
o increases FOXO3a
Findings are concordant to 4open(2019) - DOI 10.1051/fopen/2018006
appears very lucrative for hepatic carcinoma with marked escalation of NASH along with NAFLD ,liver cirrhosis -what is your opinion about MMP's role
Kulvinder kochar kaur
Thank you
- I would guess, we provided the appropriate answer within the
Special Issue and
https://bit.ly/3lFVdTM
it's figures
(attached a modifed one)
thanks i will see backwards as not keeping well so not pursued following this -kulvinder
actually due to poor vision i failed to appreciate the MMP'S already shown in the figure only after downloading and in a bigger version saw the interactions of all MMP'S IN THIS VERY DIAGRAM-Good work-Congratulations